EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout

Lindsay N Helget iD, James R O'Dell, Jeff A Newcomb, Maria Androsenko, Mary T Brophy, Anne Davis-Karim, Bryant R England iD, Ryan Ferguson, Michael H Pillinger iD, Tuhina Neogi iD, Paul M Palevsky, Hongsheng Wu und 2 weitere

Arthritis & Rheumatology · 2024

DOI: 10.1002/art.42731 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Lindsay N Helget und 13 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha. Hauptthemen laut MEDLINE: Allopurinol, Gout. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NCATS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Using trial data comparing treat‐to‐target allopurinol and febuxostat in gout, we examined participant characteristics associated with serum urate (SU) goal achievement.

Methods

Participants with gout and SU ≥6.8 mg/dL were randomized to allopurinol or febuxostat, titrated during weeks 0 to 24, and maintained weeks 25 to 48. Participants were considered to achieve SU goal if the mean SU from weeks 36, 42, and 48 was

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllopurinolGoutHumansUric AcidFebuxostatGout SuppressantsGoalsQuality of LifeTreatment OutcomeDiuretics

Substanzen

AllopurinolUric AcidFebuxostatGout SuppressantsDiuretics

Autor:innen und Institutionen

  • Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha.
  • VA Boston Cooperative Studies Program Coordinating Center, Boston, Massachusetts.
  • VA Boston Cooperative Studies Program Coordinating Center and Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
  • VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New Mexico.
  • VA New York Harbor Health Care System and New York University Grossman School of Medicine, New York.
  • Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.

ORCID-Profile: Lindsay N Helget, Bryant R England, Michael H Pillinger, Tuhina Neogi, Ted R Mikuls

Förderung

  • CSRD VA
  • NCATS NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • VA
  • BLRD VA
  • NIAMS NIH HHS
  • CSP VA

Zitieren

APA

Helget, L. N., O'Dell, J. R., Newcomb, J. A., Androsenko, M., Brophy, M. T., Davis-Karim, A., England, B. R., Ferguson, R., Pillinger, M. H., Neogi, T., Palevsky, P. M., Wu, H., Kramer, B., & Mikuls, T. R. (2024). Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout. Arthritis & Rheumatology. https://doi.org/10.1002/art.42731

Vancouver

Helget LN, O'Dell JR, Newcomb JA, Androsenko M, Brophy MT, Davis-Karim A, et al. Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout. Arthritis & Rheumatology. 2024. doi:10.1002/art.42731

BibTeX
@article{Helget2024,
  author = {Helget, Lindsay N and O'Dell, James R and Newcomb, Jeff A and Androsenko, Maria and Brophy, Mary T and Davis-Karim, Anne and England, Bryant R and Ferguson, Ryan and Pillinger, Michael H and Neogi, Tuhina and Palevsky, Paul M and Wu, Hongsheng and Kramer, Bridget and Mikuls, Ted R},
  title = {Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  doi = {10.1002/art.42731}
}
Kostenlos starten →